BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 7:26:00 PM | Browse: 990 | Download: 868
Publication Name World Journal of Gastroenterology
Manuscript ID 5721
Country United States
Received
2013-09-23 09:55
Peer-Review Started
2013-09-24 10:03
To Make the First Decision
2013-10-14 21:15
Return for Revision
2013-10-16 10:04
Revised
2013-12-18 23:29
Second Decision
2014-04-03 10:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-03 12:25
Articles in Press
2014-05-23 10:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-14 17:40
Publish the Manuscript Online
2014-07-14 17:39
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Daniel Delitto, Eva Vertes-George, Steven J Hughes, Kevin E Behrns and Jose G Trevino
Funding Agency and Grant Number
Corresponding Author Jose G Trevino, MD, Department of Surgery, University of Florida-Gainesville, 1600 SW Archer Rd, Rm 6175, PO Box 100109, Gainesville, FL 32610, United States. jose.trevino@surgery.ufl.edu ID:00006265
Key Words Pancreatic adenocarcinoma; c-Met; Chemoresistance; Receptor tyrosine kinase
Core Tip As one of the leading causes of cancer-related deaths, pancreatic cancer remains elusive to our current therapeutic options. These modest advances in current therapies for pancreatic cancer have led to the recognition and development of targeted therapies toward tyrosine kinase receptors such as the c-Met receptor. In this review, we characterize the role of c-Met in the development of tumorigenesis, metastasis and chemoresistance, highlighting the potential of c-Met as a therapeutic target in pancreatic cancer.
Publish Date 2014-07-14 17:39
Citation Delitto D, Vertes-George E, Hughes SJ, Behrns KE, Trevino JG. c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8458-8470
URL http://www.wjgnet.com/1007-9327/full/v20/i26/8458.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i26.8458
Full Article (PDF) WJG-20-8458.pdf
Full Article (Word) WJG-20-8458.doc
Manuscript File 5721-Review.doc
Answering Reviewers 5721-Answering reviewers.pdf
Copyright License Agreement 5721-Copyright assignment.pdf
Peer-review Report 5721-Peer reviews.pdf
Scientific Editor Work List 5721-Scientific editor work list.doc